High frequency of the 844ins68 cystathionine-β-synthase gene variant in Down syndrome children with acute myeloid leukemia [7]

Leukemia

Volumn 16, Issue 11, 2002, Pages 2339-2341

  Ge, Y ^a   Jensen, T ^a   James, S J ^b   Becton, D L ^c   Massey, G V ^d   Weinstein, H J ^e   Ravindranath, Y ^a,f,g   Matherly, L H ^a,g   Taub, J W ^a,f,g  

^a KARMANOS CANCER INSTITUTE   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c UNIVERSITY OF ARKANSAS   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^g WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; GENOMIC DNA; HOMOCYSTEINE; METHIONINE SYNTHASE; RNA;

ACUTE GRANULOCYTIC LEUKEMIA; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DOWN SYNDROME; DRUG SENSITIVITY; ENZYME POLYMORPHISM; EXON; FISHER EXACT TEST; FOLATE METABOLISM; FRACTIONATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTELLIGENCE QUOTIENT; LETTER; MYELOBLAST; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STATISTICAL ANALYSIS;

EID: 0036850536     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402705     Document Type: Letter

References (8)

1. Tsai MY, Bignell M, Schwichtenberg K, Hanson NQ High prevalence of a mutation in the cystathionine β-synthase gene. Am J Hum Genet 1996; 59: 1262-1267.
2. Taub JW, Huang X, Matherly LH, Stout ML, Buck SA, Massey GV, Becton DL, Chang MN, Weinstein HJ, Ravindranath Y. Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin. Blood 1999; 94: 1393-1400.
3. Taub JW. The relationship of chromosome 21 and acute leukemia in Down syndrome and non-Down syndrome children. J Pediatr Hematol Oncol 2001; 23:175-178.
4. Barbaux S, Plomin R, Whitehead AS. Polymorphisms of genes controlling homocysteine/folate metabolism and cognitive function. Neuroreport 2000; 11: 1133-1136.
5. Tsai MY, Yang F, Bignell M, Aras O, Hanson NQ. Relationship between plasma homocysteine concentration, the 844ins68 variant of the cystathionine beta-synthase gene, and pyridoxal-5′-phosphate concentration. Mol Genet Metab 1999; 67: 352-356.
6. Silaste ML, Rantala M, Sämpi M, Alfthan G, Aro A, Kesäniemi YA. Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. J Nutr 2001; 131: 2643-2647.
7. James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 1999; 70: 495-501.
8. Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, Pogribna M, Rozen R, James SJ. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 2000; 67: 623-630.